Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8491 to 8505 of 8900 results

  1. Diabetes: annual urinary albumin (children) (IND52)

    This indicator has been updated and replaced by NICE indicator 304 and NICE indicator 305.

    Withdrawn indicator

  2. Diabetes: annual BMI (children) (IND50)

    This indicator has been updated and replaced by NICE indicator 300 and NICE indicator 301.

    Withdrawn indicator

  3. Diabetes: annual blood pressure (children) (IND51)

    This indicator has been updated and replaced by NICE indicator 302 and NICE indicator 303.

    Withdrawn indicator

  4. Diabetes: annual HbA1c (children) (IND49)

    This indicator has been updated and replaced by NICE indicator 298 and NICE indicator 299.

    Withdrawn indicator

  5. Diabetes: annual care processes (children) (IND48)

    This indicator has been updated and replaced by NICE indicator 296 and NICE indicator 297.

    Withdrawn indicator

  6. Cardiovascular disease prevention: cholesterol treatment target (secondary prevention) (IND268)

    This indicator has been updated and replaced by NICE indicator 278.

    Withdrawn indicator

  7. Kidney conditions: CKD and SGLT2 inhibitors (IND262)

    This indicator has been updated and replaced by NICE indicator 322.

    Withdrawn indicator

  8. Multiple long-term conditions: falls prevention advice (IND209)

    This indicator has been removed following the publication of NICE guideline NG249.

    Withdrawn indicator

  9. Heart failure: beta blockers (IND194)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  10. Heart Failure: ACEi or ARBs (IND193)

    This indicator has been updated and replaced by NICE indicator 317.

    Withdrawn indicator

  11. Asthma: annual review (IND188)

    This guidance has been updated and replaced by NICE indicator 273.

    Withdrawn indicator

  12. Asthma: objective tests (IND187)

    This guidance has been updated and replaced by NICE indicator 272.

    Withdrawn indicator

  13. COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 (ES24)

    This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.

    Withdrawn advice

  14. COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES23)

    This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.

    Withdrawn advice

  15. COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn advice